ZAFRILLA 2mg tablets medication leaflet

G03DB08 dienogest • Genito urinary system and sex hormones | Progestogens | Pregnadien derivatives

Dienogest is a progestin primarily used to treat endometriosis, a condition in which endometrial tissue grows outside the uterus, causing pain and other symptoms. It works by reducing estrogen production and inhibiting the growth of endometrial tissue.

The medication is taken orally, usually once daily, as directed by a doctor.

Side effects may include headaches, nausea, weight changes, or irregular menstrual bleeding. In rare cases, more severe adverse effects such as depression or blood clots may occur.

Patients should inform their doctor about any other medications they are taking and strictly follow the treatment regimen. Pregnant or breastfeeding women should not use this medication.

General data about ZAFRILLA 2mg

Substance: dienogest

Date of last drug list: 01-06-2025

Commercial code: W65839001

Concentration: 2mg

Pharmaceutical form: tablets

Quantity: 28

Product type: generic

Price: 44.23 RON

Prescription restrictions: P-6L - Medicines prescription that isn't retained in the pharmacy (can be renewed); the prescription can be used for 6 months from the moment of release.

Marketing authorisation

Manufacturer: GEDEON RICHTER PLC. - UNGARIA

Holder: GEDEON RICHTER ROMANIA S.A. - ROMANIA

Number: 15733/2024/01

Shelf life: 3 years

Other substances similar to dienogest